West Pharmaceutical Services, Inc. (WST)
USD 211.29
(0.49%)
USD 211.29
(0.49%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 434.7 Million USD | 4.8% |
| 2022 | 414.8 Million USD | 9.62% |
| 2021 | 378.4 Million USD | 17.77% |
| 2020 | 321.3 Million USD | 36.32% |
| 2019 | 235.7 Million USD | 9.88% |
| 2018 | 214.5 Million USD | -0.33% |
| 2017 | 215.2 Million USD | 7.98% |
| 2016 | 199.3 Million USD | 10.05% |
| 2015 | 181.1 Million USD | -0.22% |
| 2014 | 181.5 Million USD | 2.6% |
| 2013 | 176.9 Million USD | 9.06% |
| 2012 | 162.2 Million USD | 6.85% |
| 2011 | 151.8 Million USD | 3.27% |
| 2010 | 147 Million USD | 13.78% |
| 2009 | 129.2 Million USD | 11.67% |
| 2008 | 115.7 Million USD | 3.49% |
| 2007 | 111.8 Million USD | 14.67% |
| 2006 | 97.5 Million USD | 59.31% |
| 2005 | 61.2 Million USD | 7.94% |
| 2004 | 56.7 Million USD | 18.13% |
| 2003 | 48 Million USD | 16.22% |
| 2002 | 41.3 Million USD | 20.41% |
| 2001 | 34.3 Million USD | -16.34% |
| 2000 | 41 Million USD | -2.61% |
| 1999 | 42.1 Million USD | -3.22% |
| 1998 | 43.5 Million USD | 13.58% |
| 1997 | 38.3 Million USD | -12.95% |
| 1996 | 44 Million USD | -8.9% |
| 1995 | 48.3 Million USD | 26.77% |
| 1994 | 38.1 Million USD | 10.43% |
| 1993 | 34.5 Million USD | -9.21% |
| 1992 | 38 Million USD | 12.43% |
| 1991 | 33.8 Million USD | -27.16% |
| 1990 | 46.4 Million USD | 3.8% |
| 1989 | 44.7 Million USD | 4.44% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 401.2 Million USD | -4.29% |
| 2024 Q1 | 429.9 Million USD | -1.1% |
| 2024 Q2 | 419.2 Million USD | -2.49% |
| 2023 Q2 | 449.4 Million USD | 0.54% |
| 2023 FY | 434.7 Million USD | 4.8% |
| 2023 Q1 | 447 Million USD | 7.76% |
| 2023 Q3 | 431.8 Million USD | -3.92% |
| 2023 Q4 | 434.7 Million USD | 0.67% |
| 2022 Q1 | 416.5 Million USD | 10.07% |
| 2022 FY | 414.8 Million USD | 9.62% |
| 2022 Q4 | 414.8 Million USD | 0.41% |
| 2022 Q3 | 413.1 Million USD | 0.36% |
| 2022 Q2 | 411.6 Million USD | -1.18% |
| 2021 FY | 378.4 Million USD | 17.77% |
| 2021 Q4 | 378.4 Million USD | 6.95% |
| 2021 Q3 | 353.8 Million USD | 2.49% |
| 2021 Q2 | 345.2 Million USD | 11.28% |
| 2021 Q1 | 310.2 Million USD | -3.45% |
| 2020 Q4 | 321.3 Million USD | 8.95% |
| 2020 Q1 | 251 Million USD | 6.49% |
| 2020 Q3 | 294.9 Million USD | 7.31% |
| 2020 Q2 | 274.8 Million USD | 9.48% |
| 2020 FY | 321.3 Million USD | 36.32% |
| 2019 Q4 | 235.7 Million USD | 2.3% |
| 2019 FY | 235.7 Million USD | 9.88% |
| 2019 Q1 | 226.1 Million USD | 5.41% |
| 2019 Q2 | 232.3 Million USD | 2.74% |
| 2019 Q3 | 230.4 Million USD | -0.82% |
| 2018 Q4 | 214.5 Million USD | 3.72% |
| 2018 Q2 | 208.2 Million USD | -3.48% |
| 2018 Q3 | 206.8 Million USD | -0.67% |
| 2018 Q1 | 215.7 Million USD | 0.23% |
| 2018 FY | 214.5 Million USD | -0.33% |
| 2017 Q2 | 211.3 Million USD | -0.47% |
| 2017 FY | 215.2 Million USD | 7.98% |
| 2017 Q4 | 215.2 Million USD | -0.28% |
| 2017 Q3 | 215.8 Million USD | 2.13% |
| 2017 Q1 | 212.3 Million USD | 6.52% |
| 2016 Q2 | 197.7 Million USD | 1.85% |
| 2016 FY | 199.3 Million USD | 10.05% |
| 2016 Q4 | 199.3 Million USD | -0.9% |
| 2016 Q3 | 201.1 Million USD | 1.72% |
| 2016 Q1 | 194.1 Million USD | 7.18% |
| 2015 FY | 181.1 Million USD | -0.22% |
| 2015 Q2 | 187.2 Million USD | 2.07% |
| 2015 Q1 | 183.4 Million USD | 1.05% |
| 2015 Q4 | 181.1 Million USD | -3.52% |
| 2015 Q3 | 187.7 Million USD | 0.27% |
| 2014 Q2 | 187.9 Million USD | 0.21% |
| 2014 FY | 181.5 Million USD | 2.6% |
| 2014 Q4 | 181.5 Million USD | -2.26% |
| 2014 Q1 | 187.5 Million USD | 5.99% |
| 2014 Q3 | 185.7 Million USD | -1.17% |
| 2013 FY | 176.9 Million USD | 9.06% |
| 2013 Q3 | 176.7 Million USD | 0.11% |
| 2013 Q2 | 176.5 Million USD | 1.73% |
| 2013 Q1 | 173.5 Million USD | 6.97% |
| 2013 Q4 | 176.9 Million USD | 0.11% |
| 2012 FY | 162.2 Million USD | 6.85% |
| 2012 Q4 | 162.2 Million USD | -2.23% |
| 2012 Q3 | 165.9 Million USD | 4.21% |
| 2012 Q2 | 159.2 Million USD | 0.63% |
| 2012 Q1 | 158.2 Million USD | 4.22% |
| 2011 Q3 | 155.5 Million USD | -3.54% |
| 2011 Q1 | 157.1 Million USD | 6.87% |
| 2011 Q4 | 151.8 Million USD | -2.38% |
| 2011 FY | 151.8 Million USD | 3.27% |
| 2011 Q2 | 161.2 Million USD | 2.61% |
| 2010 FY | 147 Million USD | 13.78% |
| 2010 Q1 | 144.8 Million USD | 12.07% |
| 2010 Q2 | 143.3 Million USD | -1.04% |
| 2010 Q3 | 148.4 Million USD | 3.56% |
| 2010 Q4 | 147 Million USD | -0.94% |
| 2009 Q2 | 130 Million USD | 8.33% |
| 2009 Q3 | 135.9 Million USD | 4.54% |
| 2009 Q4 | 129.2 Million USD | -4.93% |
| 2009 Q1 | 120 Million USD | 3.72% |
| 2009 FY | 129.2 Million USD | 11.67% |
| 2008 FY | 115.7 Million USD | 3.49% |
| 2008 Q1 | 119.3 Million USD | 6.71% |
| 2008 Q3 | 124.7 Million USD | -2.04% |
| 2008 Q4 | 115.7 Million USD | -7.22% |
| 2008 Q2 | 127.3 Million USD | 6.71% |
| 2007 Q3 | 119.7 Million USD | 7.16% |
| 2007 Q4 | 111.8 Million USD | -6.6% |
| 2007 Q2 | 111.7 Million USD | 3.71% |
| 2007 Q1 | 107.7 Million USD | 10.46% |
| 2007 FY | 111.8 Million USD | 14.67% |
| 2006 Q1 | 86.3 Million USD | 41.01% |
| 2006 Q3 | 94.4 Million USD | 8.26% |
| 2006 Q4 | 97.5 Million USD | 3.28% |
| 2006 FY | 97.5 Million USD | 59.31% |
| 2006 Q2 | 87.2 Million USD | 1.04% |
| 2005 Q1 | 62.5 Million USD | 10.23% |
| 2005 FY | 61.2 Million USD | 7.94% |
| 2005 Q2 | 64.6 Million USD | 3.36% |
| 2005 Q3 | 64.7 Million USD | 0.15% |
| 2005 Q4 | 61.2 Million USD | -5.41% |
| 2004 Q3 | 57.9 Million USD | 4.32% |
| 2004 FY | 56.7 Million USD | 18.13% |
| 2004 Q1 | 52.2 Million USD | 8.75% |
| 2004 Q2 | 55.5 Million USD | 6.32% |
| 2004 Q4 | 56.7 Million USD | -2.07% |
| 2003 Q4 | 48 Million USD | 4.58% |
| 2003 Q2 | 45 Million USD | 6.13% |
| 2003 Q3 | 45.9 Million USD | 2.0% |
| 2003 Q1 | 42.4 Million USD | 2.66% |
| 2003 FY | 48 Million USD | 16.22% |
| 2002 Q3 | 40.4 Million USD | 0.0% |
| 2002 Q2 | 40.4 Million USD | 10.68% |
| 2002 FY | 41.3 Million USD | 20.41% |
| 2002 Q4 | 41.3 Million USD | 2.23% |
| 2002 Q1 | 36.5 Million USD | 6.41% |
| 2001 Q1 | 43.1 Million USD | 5.12% |
| 2001 Q4 | 34.3 Million USD | -19.1% |
| 2001 FY | 34.3 Million USD | -16.34% |
| 2001 Q3 | 42.4 Million USD | 2.66% |
| 2001 Q2 | 41.3 Million USD | -4.18% |
| 2000 FY | 41 Million USD | -2.61% |
| 2000 Q4 | 41 Million USD | -1.44% |
| 2000 Q3 | 41.6 Million USD | -4.81% |
| 2000 Q1 | 43.1 Million USD | 2.38% |
| 2000 Q2 | 43.7 Million USD | 1.39% |
| 1999 FY | 42.1 Million USD | -3.22% |
| 1999 Q3 | 42 Million USD | 3.7% |
| 1999 Q4 | 42.1 Million USD | 0.24% |
| 1999 Q2 | 40.5 Million USD | -1.7% |
| 1999 Q1 | 41.2 Million USD | -5.29% |
| 1998 Q1 | 43.2 Million USD | 12.79% |
| 1998 Q2 | 42.8 Million USD | -0.93% |
| 1998 Q3 | 44.8 Million USD | 4.67% |
| 1998 Q4 | 43.5 Million USD | -2.9% |
| 1998 FY | 43.5 Million USD | 13.58% |
| 1997 Q3 | 39.6 Million USD | -1.25% |
| 1997 Q1 | 43.7 Million USD | -0.68% |
| 1997 Q2 | 40.1 Million USD | -8.24% |
| 1997 Q4 | 38.3 Million USD | -3.28% |
| 1997 FY | 38.3 Million USD | -12.95% |
| 1996 FY | 44 Million USD | -8.9% |
| 1996 Q4 | 44 Million USD | -2.44% |
| 1996 Q1 | 50.4 Million USD | 4.35% |
| 1996 Q3 | 45.1 Million USD | -8.33% |
| 1996 Q2 | 49.2 Million USD | -2.38% |
| 1995 Q2 | 51.9 Million USD | 12.34% |
| 1995 Q1 | 46.2 Million USD | 21.26% |
| 1995 Q4 | 48.3 Million USD | -4.36% |
| 1995 FY | 48.3 Million USD | 26.77% |
| 1995 Q3 | 50.5 Million USD | -2.7% |
| 1994 Q2 | 38.1 Million USD | 4.38% |
| 1994 Q3 | 37.7 Million USD | -1.05% |
| 1994 Q4 | 38.1 Million USD | 1.06% |
| 1994 FY | 38.1 Million USD | 10.43% |
| 1994 Q1 | 36.5 Million USD | 5.8% |
| 1993 Q2 | 36.1 Million USD | 3.74% |
| 1993 FY | 34.5 Million USD | -9.21% |
| 1993 Q4 | 34.5 Million USD | -4.96% |
| 1993 Q3 | 36.3 Million USD | 0.55% |
| 1993 Q1 | 34.8 Million USD | -8.42% |
| 1992 Q2 | 38.5 Million USD | 1.85% |
| 1992 Q4 | 38 Million USD | -9.31% |
| 1992 FY | 38 Million USD | 12.43% |
| 1992 Q3 | 41.9 Million USD | 8.83% |
| 1992 Q1 | 37.8 Million USD | 11.83% |
| 1991 Q3 | 36.2 Million USD | -6.22% |
| 1991 Q4 | 33.8 Million USD | -6.63% |
| 1991 Q1 | 44.1 Million USD | -4.96% |
| 1991 FY | 33.8 Million USD | -27.16% |
| 1991 Q2 | 38.6 Million USD | -12.47% |
| 1990 Q1 | 47.3 Million USD | 5.82% |
| 1990 Q2 | 46.3 Million USD | -2.11% |
| 1990 Q4 | 46.4 Million USD | -2.11% |
| 1990 Q3 | 47.4 Million USD | 2.38% |
| 1990 FY | 46.4 Million USD | 3.8% |
| 1989 FY | 44.7 Million USD | 4.44% |
| 1989 Q4 | 44.7 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alcon Inc. | 2.32 Billion USD | 81.273% |
| AptarGroup, Inc. | 513.05 Million USD | 15.272% |
| Baxter International Inc. | 2.82 Billion USD | 84.607% |
| Becton, Dickinson and Company | 3.27 Billion USD | 86.719% |
| Bausch + Lomb Corporation | 1.02 Billion USD | 57.714% |
| Haemonetics Corporation | 317.2 Million USD | -37.042% |
| Envista Holdings Corp | 258.8 Million USD | -67.968% |
| ResMed Inc. | 822.25 Million USD | 47.133% |
| Teleflex Incorporated | 626.21 Million USD | 30.583% |
| Warby Parker Inc. | 62.23 Million USD | -598.493% |